ArticleBioinformation2026
Correlation between liver stiffness measurement and hepatocellular carcinoma risk: A case control study.
Article in Bioinformation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Liver stiffness measurement (LSM) using transient elastography (TE) poorly predicts hepatocellular carcinoma risk in cirrhotic patients, despite its established role in fibrosis assessment. This case-control study compared 30 hepatocellular carcinoma (HCC) patients with cirrhosis to 30 cirrhosis-only patients using FibroScan® TE for LSM. HCC patients were older, mostly male, with Hepatitis C virus (HCV) as the primary cirrhosis cause, followed by alcohol; median LSM was higher in HCC (58.0 kPa) versus non-HCC (24.5 kPa). Stratum-specific likelihood ratios rose with LSM and multivariate analysis confirmed age, HCV, alcohol and LSM as independent HCC predictors; LSM ≥39.45 kPa showed 83% sensitivity and 80% specificity for HCC detection in cirrhosis. Elevated LSM strongly associates with HCC risk, supporting TE as a non-invasive tool, especially with HCV/alcohol factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.